Literature DB >> 20859756

Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.

Xiao-Yan Wang1, Ming-Hua Wu, Fen Liu, Yu Li, Nan Li, Gui-Yuan Li, Shou-Rong Shen.   

Abstract

Nasopharyngeal carcinoma-associated gene 6 (NGX6) was shown to be a novel putative tumor suppressor gene in colon cancer. The purpose of this study is to investigate its role in regulation of miRNA expression for in the hopes of translating this data into a novel strategy in control of colon cancer. In this study colon cancer HT-29 cells were stably transfected with NGX6 or vector-only plasmid and then subjected to miRNA array analysis, and Q-RT-PCR was then used to verify miRNA array data. Then bioinformatic analyses using Sanger, Target Scan, and MicroRNA software were performed to obtain data on the target genes of each miRNA and define their function. Our results showed that 14 miRNAs were found to be differentially expressed in NGX6-transfected cells compared to the control cells. In particular, miR-126, miR-142-3p, miR-155, miR-552, and miR-630 were all upregulated, whereas miR-146a, miR-152, miR-205, miR-365, miR-449, miR-518c, miR-584, miR-615, and miR-622 were downregulated after NGX6 transfection. Q-RT-PCR confirmed all of these miRNAs, and invalidated miR-552 and miR-630. Furthermore, bioinformatic analyses of these 12 miRNAs, among these miRNAs, target genes of miR-615 are unclear, another 11 miRNAs produced a total of 254 potential target genes and further study showed that these genes together formed a regulatory network that contributes to apoptosis, mobility/migration, hydrolysis activity, and molecular signaling through targeting JNK and Notch pathways. Taken together, these results have suggested that NGX6 plays an important role in regulation of apoptosis, mobility/migration, and hydrolase as well as activity of JNK and Notch pathways through NGX6-mediated miRNA expression. Further investigation will reveal the function of these differentially expressed miRNAs and verify expression of the miRNA-targeted genes for development of novel strategies for better control of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859756     DOI: 10.1007/s11010-010-0582-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  The Notch signaling pathway: transcriptional regulation at Notch target genes.

Authors:  T Borggrefe; F Oswald
Journal:  Cell Mol Life Sci       Date:  2009-05       Impact factor: 9.261

2.  DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.

Authors:  Li Li; Masaki Miyamoto; Yuma Ebihara; Seiji Mega; Ryo Takahashi; Ryunosuke Hase; Hiroyuki Kaneko; Masatoshi Kadoya; Tomoo Itoh; Toshiaki Shichinohe; Satoshi Hirano; Satoshi Kondo
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

3.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

5.  Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Authors:  Xiao-Mei Zhang; Xiao-Yan Wang; Shou-Rong Sheng; Jie-Ru Wang; Jiang Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 6.  MicroRNAs and cancer.

Authors:  Michael T McManus
Journal:  Semin Cancer Biol       Date:  2003-08       Impact factor: 15.707

7.  microRNA-205 regulates HER3 in human breast cancer.

Authors:  Marilena V Iorio; Patrizia Casalini; Claudia Piovan; Gianpiero Di Leva; Andrea Merlo; Tiziana Triulzi; Sylvie Ménard; Carlo M Croce; Elda Tagliabue
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

9.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

10.  Suppression of cell growth and invasion by miR-205 in breast cancer.

Authors:  Hailong Wu; Shoumin Zhu; Yin-Yuan Mo
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

View more
  30 in total

1.  Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

Authors:  Zeng Li; Nan Li; Minghua Wu; Xiayu Li; Zhaohui Luo; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

2.  MicroRNA-630 is a prognostic marker for patients with colorectal cancer.

Authors:  Dake Chu; Jianyong Zheng; Jipeng Li; Yunming Li; Jian Zhang; Qingchuan Zhao; Weizhong Wang; Gang Ji
Journal:  Tumour Biol       Date:  2014-07-01

3.  NGX6a is degraded through a proteasome-dependent pathway without ubiquitination mediated by ezrin, a cytoskeleton-membrane linker.

Authors:  Li Wang; Xiaoling Li; Bo Xiang; Ming Zhou; Xiayu Li; Wei Xiong; Man Niu; Pingpin Wei; Zeyou Wang; Heran Wang; Pan Chen; Shourong Shen; Shuping Peng; Guiyuan Li
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

4.  MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.

Authors:  Hui Gong; Xiaomin Sheng; Jianhua Xue; Dongbo Zhu
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

5.  Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

Authors:  Kyriaki Bakirtzi; Maria Hatziapostolou; Iordanes Karagiannides; Christos Polytarchou; Savina Jaeger; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2011-07-30       Impact factor: 22.682

6.  DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells.

Authors:  Jian Liu; Xinjiang Zhu; Xiaoyang Xu; Dongqiu Dai
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

7.  MicroRNA-365 in macrophages regulates Mycobacterium tuberculosis-induced active pulmonary tuberculosis via interleukin-6.

Authors:  Qingzhang Song; Hui Li; Hua Shao; Chunling Li; Xiao Lu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells.

Authors:  Muliang Ding; Jianzhong Hu; Jiangdong Ni; Zhonghui Zheng; Deye Song; Junjie Wang
Journal:  Oncol Lett       Date:  2015-03-13       Impact factor: 2.967

9.  MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.

Authors:  Nan Li; Anliu Tang; Shuo Huang; Zeng Li; Xiayu Li; Shourong Shen; Jian Ma; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

10.  MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.

Authors:  Wei-Wei Shen; Zhi Zeng; Wen-Xia Zhu; Guo-Hui Fu
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.